Orthovita Submits 510(k) Application To FDA For The Use Of CORTOSS(R) Bone Augmentation Material In Vertebral Augmentation
Orthovita, Inc. (NASDAQ:VITA), a spine and orthopedic biosurgery company, announced that it has submitted a 510(k) filing to the U.S. Food and Drug Administration for the use of its CORTOSS Bone Augmentation Material in vertebral augmentation. This filing is based on data collected in three U.S.
More: continued here
Filed under: Bones on January 17th, 2008